Giovannoni G, et al. Treatment outcomes of daclizumab in patients at high risk of transitioning to secondary progressive multiple sclerosis in DECIDE. EAN 2107, O2113.
Goede uitkomsten epilepsiechirurgie bij focale corticale dysplasie type II
jul 2022 | Epilepsie